WPD Pharmaceuticals Inc. (WPDPF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | 18.02 Thousand | 229.44 Thousand | 307.51 Thousand | 85.55 Thousand | - |
| Gross Profit | - | -18.02 Thousand | -229.44 Thousand | -307.51 Thousand | -85.55 Thousand | - |
| Operating Expenses | 171.5 Thousand | 1.7 Million | 4.77 Million | 6.33 Million | 8.81 Million | 531.51 Thousand |
| Selling, General and Administrative Expenses | 171.5 Thousand | 1.68 Million | 4.72 Million | 5.9 Million | 2.4 Million | 531.51 Thousand |
| Research and Development Expenses | - | - | -3402.74 | 363.89 Thousand | 74.85 Thousand | - |
| Other Expenses | - | -13.85 Thousand | -55.56 Thousand | -59.95 Thousand | - | - |
| Cost and Expenses | 171.5 Thousand | 1.71 Million | 5 Million | 6.63 Million | 8.89 Million | 531.51 Thousand |
| Operating Income | -171.5 Thousand | -1.71 Million | -5 Million | -6.63 Million | -2.64 Million | -531.51 Thousand |
| Interest Expense | 29.91 Thousand | 167.52 Thousand | 70 Thousand | 17.05 Thousand | - | 1653.85 |
| Income Tax Expense | -19.61 | 2.21 | 4.74 | - | 0.76 | - |
| Earnings before Tax | -60.44 Thousand | 2.84 Million | -4.44 Million | -5.9 Million | -8.94 Million | -593.49 Thousand |
| Net Income | -60.44 Thousand | 2.84 Million | -4.44 Million | -5.9 Million | -8.94 Million | -593.49 Thousand |
| Earnings Per Share Basic | -0.00 | 0.03 | -0.04 | -0.05 | -2.62 | -0.03 |
| Earnings Per Share Diluted | -0.00 | 0.03 | -0.04 | -0.05 | -2.62 | -0.03 |
| Weighted Average Shares Outstanding | 113.59 Million | 113.43 Million | 113.43 Million | 113.12 Million | 3.41 Million | 21.41 Million |
| Weighted Average Shares Outstanding (Diluted) | 113.43 Million | 113.43 Million | 113.43 Million | 113.12 Million | 3.41 Million | 21.41 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -176.02 Thousand | 2.98 Million | -4.14 Million | -5.58 Million | -2.6 Million | -531.51 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 62.94 Thousand | 101.45 Thousand | 66.27 Thousand | 202.89 Thousand | 46.07 Thousand | 60.73 Thousand |
| Selling, General and Administrative Expenses | 62.94 Thousand | 101.45 Thousand | 66.27 Thousand | - | 46.07 Thousand | 60.73 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 10.19 Thousand | - | - | - | - | - |
| Cost and Expenses | 62.94 Thousand | 101.45 Thousand | 66.27 Thousand | 202.89 Thousand | 46.07 Thousand | 60.73 Thousand |
| Operating Income | -62.94 Thousand | -101.45 Thousand | -66.26 Thousand | -202.89 Thousand | -46.07 Thousand | -60.73 Thousand |
| Interest Expense | 16.09 Thousand | 15.37 Thousand | 10.05 Thousand | 29.91 Thousand | 15.7 Thousand | 3765.21 |
| Income Tax Expense | -2705.00 | -2705.00 | -43.81 Thousand | -167.89 Thousand | -3508.00 | -122.08 Thousand |
| Earnings before Tax | -13.88 Thousand | -116.35 Thousand | 92.34 Thousand | -60.42 Thousand | -63.19 Thousand | -59.33 Thousand |
| Net Income | -13.88 Thousand | -116.35 Thousand | 92.34 Thousand | -60.42 Thousand | -63.19 Thousand | -59.33 Thousand |
| Earnings Per Share Basic | -0.00 | -0.00 | 0.00 | - | -0.00 | -0.00 |
| Earnings Per Share Diluted | -0.00 | -0.00 | 0.00 | - | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | 113.78 Million | 113.43 Million | 113.43 Million | 113.43 Million | 113.43 Million | 113.43 Million |
| Weighted Average Shares Outstanding (Diluted) | 113.78 Million | 113.43 Million | 113.43 Million | 113.43 Million | 113.43 Million | 113.43 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -62.94 Thousand | -101.45 Thousand | -66.26 Thousand | - | -46.07 Thousand | -60.73 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
JAGX
0332
1165
TENX
IIPR
6183